These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10529321)

  • 1. Improving outcome in acute coronary syndromes - as good as it gets?
    Purcell H; Fox KM
    Eur Heart J; 1999 Nov; 20(21):1533-7. PubMed ID: 10529321
    [No Abstract]   [Full Text] [Related]  

  • 2. The Editor's Roundtable: arterial thrombosis and acute coronary syndromes.
    Friedewald VE; Bates ER; Granger CB; Yusuf S; Roberts WC
    Am J Cardiol; 2007 Sep; 100(6):974-80. PubMed ID: 17826381
    [No Abstract]   [Full Text] [Related]  

  • 3. Contemporary view of the acute coronary syndromes.
    Moustapha A; Anderson HV
    J Invasive Cardiol; 2003 Feb; 15(2):71-9. PubMed ID: 12556619
    [No Abstract]   [Full Text] [Related]  

  • 4. Enoxaparin and dalteparin in unstable angina: new indication. Enoxaparin: a reference treatment. Dalteparin: no better than unfractionated heparin.
    Prescrire Int; 1999 Jun; 8(41):77-80. PubMed ID: 10558446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New trials of LMW heparins - light and heavy weight as good on short but what about longer distances?
    Wallentin L
    Eur Heart J; 1999 Nov; 20(21):1522-4. PubMed ID: 10529316
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-molecular-weight heparin and platelet glycoprotein IIb/IIIa receptor blockade in the treatment of acute coronary syndromes: complementary or competing therapies?
    White HD
    J Invasive Cardiol; 2000 Feb; 12 Suppl A():6A-13A. PubMed ID: 10731290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-thrombotic therapy for elderly patients with acute coronary syndromes.
    Chen YT; Tuohy ER; Krumholz HM
    Coron Artery Dis; 2000 Jun; 11(4):323-30. PubMed ID: 10860175
    [No Abstract]   [Full Text] [Related]  

  • 8. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
    Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
    Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of unstable angina and non-ST-segment elevation myocardial infarction.
    Hanley HG; Nylk TM; Nguyen N
    J La State Med Soc; 2001 Jun; 153(6):306-11. PubMed ID: 11480381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet glycoprotein IIb/IIIa inhibitor therapy in non-ST segment elevation acute coronary syndromes.
    Elmouchi DA; Bates ER
    Minerva Cardioangiol; 2003 Oct; 51(5):547-60. PubMed ID: 14551523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of low-molecular-weight heparins in non-ST-segment elevation acute coronary syndromes.
    Nguyen-Ho P; Levine GN
    Panminerva Med; 2002 Jun; 44(2):115-22. PubMed ID: 12032429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A contemporary assessment of low-molecular-weight heparin for the treatment of acute coronary syndromes: factoring in new trials and meta-analysis data.
    Topol EJ
    Am Heart J; 2005 Apr; 149(4 Suppl):S100-6. PubMed ID: 16124950
    [No Abstract]   [Full Text] [Related]  

  • 13. Low molecular weight heparins in acute coronary syndrome.
    Creekmore F
    S D J Med; 2000 Jan; 53(1):21-3. PubMed ID: 10652862
    [No Abstract]   [Full Text] [Related]  

  • 14. The combination of enoxaparin, glycoprotein IIb/IIIa inhibitors and an early invasive approach among acute coronary syndrome patients.
    Lee DS; Bhatt DL; Moliterno DJ; Peacock WF; Ellis SG; Topol EJ
    J Invasive Cardiol; 2004 Feb; 16(2):46-51. PubMed ID: 14760188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological treatment of acute coronary syndromes.
    Hughes K
    Prof Nurse; 2003 Jan; 18(5):296-9. PubMed ID: 12599964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordinated series of studies to evaluate characteristics and mechanisms of acute coronary syndromes in high-risk patients randomly assigned to enoxaparin or unfractionated heparin: design and rationale of the SYNERGY Library.
    Petersen JL; Mahaffey KW; Becker RC; Goodman SG; Kleiman NS; Marian AJ; Stone GW; Lansky AJ; Lincoff AM; Hazen SL; Nessel CC; Toro-Figueroa L; Tate L; Reist CJ; Cohen M; Califf RM; Ferguson JJ;
    Am Heart J; 2004 Aug; 148(2):269-76. PubMed ID: 15308996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial experience with the low-molecular-weight heparin, enoxaparin, in combination with the platelet glycoprotein IIb/IIIa blocker, tirofiban, in patients with non-ST segment elevation acute coronary syndromes.
    Cohen M
    J Invasive Cardiol; 2000 Dec; 12 Suppl E():E5-9;discussion E25-8. PubMed ID: 11156722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Care for life. Central is the patient].
    Hilpert U
    Internist (Berl); 2000 Jan; 41(1):A37. PubMed ID: 10712086
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing coronary revascularization.
    Popma JJ
    Haemostasis; 1999 Dec; 29 Suppl S1():69-71. PubMed ID: 10629407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A perspective on trials comparing enoxaparin and unfractionated heparin in the treatment of non-ST-elevation acute coronary syndromes.
    Califf RM; Petersen JL; Hasselblad V; Mahaffey KW; Ferguson JJ
    Am Heart J; 2005 Apr; 149(4 Suppl):S91-9. PubMed ID: 16124953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.